The High Court’s Dangerous Reset On Gene Patents

Law360, New York (July 15, 2013, 11:08 AM EDT) -- Reading U.S. Supreme Court Justice Clarence Thomas’ opinion in Myriad, one might get the sense that it was the easiest case the court has decided in a long while. The court seemed to say: Of course isolated human genes are a product of nature and cannot be patented;[1] of course, cDNA[2] is self-evidently something new and must be patent-worthy. In many ways, this is true. As expressed by the numerous press accounts commenting on the decision, there is an intuitive sense of unfairness in the notion...
To view the full article, register now.